The epicardial cell (EpiC) culture system plays an important role in investigating the specific mechanisms and signaling molecules that are involved in the development of EpiCs. From this early formation until adulthood, EpiCs undergo dynamic changes in the expression of embryonic genes that correlate with changes in the embryonic EpiC properties. The differences of embryonic EpiC properties may affect the related results of experiments in which EpiC culture system is used; however, these differences have not been explored. Therefore, in this study we examined the differences in the biological characteristics of EpiCs on different embryonic days in vitro. EpiCs were isolated from embryonic ventricle explants on embryonic day (E) 11.5, E13.5, and E15.5. The differences in the migration, proliferation and differentiation were studied in EpiCs of different embryonic day by scratch assay, cell cycle analysis and platelet derived growth factor-bb (PDGF-BB) treatment. The results showed that EpiCs were successfully cultured from E11.5, E13.5, and E15.5 embryonic ventricle explants. The time windows of E11.5, E13.5, and E15.5 EpiC isolation out of the explants were different. The migration abilities of E11.5, E13.5, and E15.5 EpiCs decreased during embryonic development. Smooth muscle cell differentiation potential of early stage EpiCs was better than that of the later stage EpiCs. Although the proliferation ability of E11.5 EpiCs was significantly weaker than those of E13.5 and E15.5 EpiCs, the proliferation abilities of E13.5 and E15.5 EpiCs did not differ. These results suggest that the biological characteristics of EpiCs correlate with the timing of embryonic development, and different embryonic stage of ventricle should be properly chosen for culturing EpiCs depending on the purposes of the specific experiments.
Introduction
The epicardium (EP) is the outermost epithelial cell layer that overlays the heart, which plays important roles in the development of the heart and in the formation of the coronary vascular system [1, 2] . The EP is derived from this proepicardial organ, which is located at the venous pole of the heart and is part of the septum transversum. From E9.0 in mouse gestation, the proepicardium (PE) migrates and adheres to the surface of the primary heart tube, spreading and forming a continuous epithelial layer at approximately E10.5. The EP is fully matured by E11.5 [3, 4] . A subset of epicardial cells (EpiCs) undergoes epithelial-mesenchymal transition (EMT) to generate epicardial-derived cells (EPDCs) which migrate into the subepicardial space and further invade the underlying myocardium. Then the EPDCs differentiate into various cardiac cells [5] [6] [7] [8] [9] . Recent studies have suggested that epicardial adipose tissue is derived from EpiCs [10, 11] . Genetic fate-mapping studies have probably cleared the differentiated fate of epicardial progenitors [12] [13] [14] [15] [16] , but the specific mechanisms and signaling molecules that are involved in the differentiation of these progenitors are not clear. The EpiC culture system provides an alternative approach to investigate these mechanisms in detail during differentiation [17] [18] [19] [20] .
Current sources of embryonic EpiCs are avian embryos and mouse embryos [5, 21] . Because mouse embryos are easy to obtain and have high gene homology with humans, they are the main source of embryonic EpiCs. Essentially, the methods to isolate EpiCs include either the migration of cells from an excised heart onto a culture dish in media or fluorescence activated cell sorting (FACS) analysis of the cells from enzymatically digested heart tissue. Flow cytometry can provide highly pure EpiCs [22] ; however, this method is complex, thus limiting its application. The most common approach is the direct selection of embryonic ventricular tissue to isolate EpiCs, and E10.5-E13.5 embryonic ventricles are usually used to isolate EpiCs [17, 18, 20, 21, 23] . From this early formation of the EP until adulthood, EpiCs undergo dynamic changes in the expression of embryonic genes that correlate with changes in the embryonic EpiC properties such as proliferation, plasticity, and migration [24, 25] . The differences of embryonic EpiC properties may affect the related results of experiments in which EpiCs are used, but these differences have not been examined. EpiCs of high purity and with good biological characteristics can provide a good model for in vitro studies. Therefore, in this study we determined the differences in the biological characteristics of EpiCs on different embryonic days in vitro.
Materials and Methods
E11.5, E13.5, and E15.5 pregnant mouse selection and ethics statement C57BL/6 mice from Laboratory Animal Center of Chongqing Medical University (Chongqing, China) were mated (according to a male:female ratio of 2:3, respectively) in the afternoon on the first day. Females were checked each morning for vaginal plugs. If the vaginal plug was observed, the age of its embryos was taken as E0.5, and females were separately housed. obtained from the Jackson Laboratory (Sacramento, USA). Transgenic mice were bred and identified as described previously [26] .
Primary culture of EpiCs
Primary culture of EpiCs was performed according to the literatures [17, 18, 20, 21, 23] with appropriate adjustments. Six-well culture plates were coated with a sterile 1% gelatin solution. If EpiCs were analyzed by immunofluorescence or X-gal staining, they were cultured on coverslips. In this case, sterile coverslips were placed into the well before the wells were coated with gelatin solution. Timedpregnant mice were euthanized by cervical dislocation. Intact embryos were removed from pregnant mice using sterile forceps and scissors. The fetal heart was carefully detached under the stereomicroscope in a 60-mm culture dish filled with sterile ice-cold phosphate-buffered saline (PBS), and the atrium and the outflow tract of the left ventricle were removed. The ventricle was transferred to a 50-ml centrifuge tube with Dulbecco's modified Eagle's medium (DMEM) containing 4.5 g/l glucose (Gibco, Carlsbad, USA) and stored on ice. The excised ventricular tissue must be seeded within 1 h. The ventricle was transferred to a 6-well plate to ensure that it was in the center of each well, or transferred to a glass coverslip if the cells were used for experiments that required a large number of cells, such as polymerase chain reaction (PCR) or FACS. Two to three ventricles could be seeded in each well. The appropriate volume of DMEM was added to keep the ventricular tissue wet. A glass coverslip (not gelatin-coated) was carefully placed over the ventricle to prevent the tissue from floating. A certain volume of DMEM/10% (v/v) fetal bovine serum (FBS) was gently added at the rim of the well and not directly on the coverslip. The plate was gently transferred into a humidified incubator and cultured at 37°C in 5% CO 2 . All primary EpiC cultures were used without passage.
Immunofluorescence assay
Primary EpiCs cultured on coverslips were first fixed with 4% (wt/vol) paraformaldehyde for 10 min at room temperature. Then, the cells were permeabilized with 0.25% (vol/vol) Triton X-100 in PBS for 10 min at 37°C. , and the cell nuclei were stained with 4', 6-diamidino-2-phenylindole (DAPI) for 8 min at room temperature. The coverslip was mounted upside down on glass microscope slides using antifade polyvinylpyrrolidone mounting medium. The images were acquired within 2-3 days using a Nikon A1+R confocal laser microscope (Nikon, Tokyo, Japan).
Quantitative PCR (qPCR)
Total RNA was extracted from the cells using TRIzol reagent (TaKaRa, Dalian, China) according to the manufacturer's instructions. Reverse transcription was performed using a PrimeScript Reverse Transcriptase Reagent Kit (TaKaRa) with 1 µg of total RNA. qPCR was performed on a C1000 thermal cycler (BioRad, Hercules, USA) under the following cycle conditions: 95°C for 30 s, followed by 95°C for 5 s, 60°C for 30 s, and 72°C for 30 s for 40 cycles. SYBR premix Ex Taq (TaKaRa) was used in each reaction. The relative gene expression level was determined by normalizing the results to GAPDH mRNA expression (as an internal control) using the 2 -ΔΔCT method.
The sequences of primers used were as follows: TBX18-F: 5′-TCGAT ACAGCACATCCTTGG-3′ and TBX18-R: 5′-GCTGCTCACACT CACGTAGG-3′; WT1-F: 5′-ATCCGCAACCAAGGATACAG-3′ and WT1-R: 5′-CCTCGTGTTTGAAGGAATGG-3′; TNNT2-F: 5′-CCGA TGGAGAGAGAGTGGAC-3′ and TNNT2-R: 5′-TGTCTTTGAGGG AAATCAGC-3′. Each gene was analyzed in triplicate.
Scratch assay
Wound scratch/migration assays were performed according to the literatures [27] [28] [29] with appropriate adjustments. EpiCs were trypsinized to obtain cell suspensions which were plated in 12-well plates at a density of 10 5 cells/well. After the cells had reached confluence in the center of the well, the cells were serum-starved for 12 h. A cross was introduced in the central area of the confluent cell mass, which was marked with a marker pen at the bottom of the plate. The culture was carefully washed with serum-free medium to remove detached cells, and fresh DMEM/1%FBS medium were added and cultured for an additional 24 h. Images were captured at 0 and 24 h after scratching under an inverted microscope (Nikon). The width of the scratch was measured using Image-Pro Plus 6.0 software. As described previously [27] , the migration distance was calculated by subtracting the width at 24 h from the original wound width at 0 h and divided by 2, i.e. (W 0 -W 24 )/2. The migration assays were repeated three times in each experimental group. Images of each well at each time point were randomly collected in each direction. Four images were analyzed per well at each time point. The images taken at 0 h and 24 h in the same well were consistent.
Cell cycle analysis
Cell cycle analysis was performed by flow cytometry. After EpiCs were cultured for 3 days, they were harvested by trypsin digestion. The cells were washed twice with sterile PBS and subsequently fixed with cold 70% ethanol overnight at 4°C. After the cells were fixed, they were suspended in FACS buffer containing propidium iodide and RNase and incubated for 1 h at room temperature. Then, DNA content was measured using FACS influx (BD, Franklin Lakes, USA). The distributions of G0/G1, S, and G2/M phases were analyzed. Cell cycle analysis was repeated six times in each group.
EpiC differentiation induction
Cell differentiation induction was performed according to the literatures [20, 23, 30, 31] with appropriate adjustments. Recombinant human PDGF-BB (R&D Systems, Minneapolis, USA) was used to induce smooth muscle cell (SMC) differentiation of EpiCs. PDGF-BB culture medium (20 ng/ml) was added on the day of heart removal, and the medium was replaced daily to provide adequate PDGF-BB. Bovine serum albumin (BSA) was used as the control. After treatment, the cells were immunofluorescently stained for α-smooth muscle actin (α-SMA) and myosin heavy chain 11 (MYH11).
X-gal staining
EpiCs were fixed in fixing solution (1% paraformaldehyde, 0.2% glutaraldehyde, 2 mM MgCl 2 , and 5 mM EGTA in PBS) for 10 min at room temperature. After fixation, the cells were washed three times with washing buffer (2 mM MgCl 2 , 0.02% NP-40, and 0.01% sodium deoxycholate in PBS). EpiCs were stained with X-gal staining solution (5 mM K-ferricyanide, 5 mM K-ferrocyanide, 2 mM MgCl 2 , 0.01% sodium deoxycholate, 0.02% NP-40, and 0.1% X-gal in PBS) for 1-24 h at 37°C. After being stained, the cells were gradually dewatered in gradient alcohol. The coverslip with EpiCs was mounted upside down on glass microscope slides using neutral balsam mounting medium.
Statistical analysis
All data are expressed as the mean ± standard deviation. Statistical analysis was performed using Student's t-test to compare data between two groups. One-way ANOVA was applied to analyze the data using SPSS software. P < 0.05 was considered as statistically significant.
Results
Primary culture of EpiCs from E11.5, E13.5, and E15.5 mouse
EpiCs migrated out of the E11.5 embryonic ventricle explant onto the surface of the culture plate after 24 h following plantation. The cells formed a monolayer mosaic arrangement that surrounded the ventricle explant (Fig. 1A) . Under the optical microscope at higher magnification, the EpiCs showed typical epithelial cell morphology (cobblestone-like shape) (Fig. 1I) . These cells were positive for the epicardial markers t-box transcription factor 18 (TBX18) and wilms' tumor 1 homolog (WT1), which confirms their epicardial identity (Fig. 1G,H) . These cells presented high levels of mRNA expression of TBX18 and WT1 but not of the cardiomyocyte marker troponin T type 2 (TNNT2) (Fig. 1J) . In addition, staining for the tight junction marker ZO-1 showed close contacts between the cells, further confirming their epithelial nature (Fig. 1E) .
Using the same method, E13.5 and E15.5 EpiCs were successfully cultured. To analyze the purity of EpiCs, TBX18 antibodies were used to mark EpiCs versus other contaminating cell types. EpiCs were quantified by dividing the number of TBX18-positive cells by the total number of DAPI-positive cells assayed in three separate ventricle explants. The results indicated that 95.63% ± 1.08% of E11.5 spreading cells was of EP origin, 96.57% ± 1.01% of E13.5 spreading cells was of EP origin, and 98.33% ± 0.60% of E15.5 spreading cells was of EP origin (data not shown). Notably, the purity of EpiCs was dependent on the quality of embryonic ventricle isolation.
E11.5, E13.5, and E15.5 EpiC migration out of the ventricle requires different time windows
The EP is fully matured by E11.5 [3, 4] . In vivo studies have demonstrated that the epicardial-specific transcription factors WT1, TBX18, and epicardin/TCF21 are still expressed in the EP at E16.5 [13, 18, 32, 33] . E11.5, E13.5, and E15.5 embryonic ventricles were selected in this study to culture and to observe the conditions and the time windows of EpiC migration out of the ventricle (for recommended time, refer to Table 1 ). Enough EpiCs were able to migrate out of the E11.5 embryonic ventricle explants in DMEM/10%FBS or in serum-free medium after 24 h following plantation. However, overall, the cells in 10% FBS culture medium grew better than those in serum-free medium. Cells did not survive well in long-term serum-free culture and began to die after 4 or 5 days. Only a few cells migrated out of the E13.5 embryonic ventricle explants after 24 h (Fig. 1B) , and none of the cells migrated out of the E15.5 embryonic ventricle explants (Fig. 1C) . Outgrowth of the EpiCs was sufficient only when the cells were cultured for an additional 2-3 days (Fig. 1D) . Moreover, few EpiCs migrated out of E13.5 and E15.5 embryonic ventricle explants under serum-free conditions, even with long-term culture. Generally, the capacity of EpiCs to migrate out from E11.5, E13.5, and E15.5 embryonic ventricle explants decreased as embryonic development progressed.
Early stage EpiCs are more susceptible to undergo mesenchymal transition than later stage EpiCs
After the cells were cultured for 2 days, the cells in the periphery of the E15.5 cell mass maintained typical epicardial mesothelial cell morphology (cobblestone-like), but some cells in the periphery of the E11.5 and E13.5 cell mass began to undergo mesenchymal transition, presenting altered cell morphology (enlarged). The number of enlarged cells were increased as the culture time is increased ( Fig. 2A) . According to the literature [20] with appropriate adjustments, the counted areas were determined such as 500 μm from the edge of cell mass. We defined compact cobblestone-like cells smaller than 0.0025 mm 2 as 'cobblestone-like', and the proportion of enlarged cells in the total cells was calculated. The results indicated that the proportion of enlarged cells was higher for early stage EpiCs than that for later stage EpiCs during the same culture time (Fig. 2B) . The mRNA expression levels of N-cadherin decreased in E11.5, E13.5 and E15.5 EpiCs on day 2, and the difference was distinguishable on day 6 (Fig. 2C) . These results suggest that early stage EpiCs are more susceptible to undergo mesenchymal transition than later stage EpiCs.
The migration abilities of E11.5, E13.5, and E15.5 EpiCs decrease as embryonic development progresses Scratch assay can simulate the sideway migration of cells. Serum starvation of cells for 12 h inhibits cell proliferation, while culturing cells in DMEM/1%FBS allows cells to migrate in a low proliferation state to prevent cell death. E11.5 EpiCs completely migrated across the scratch in 24 h, but the scratches in E13.5 and E15.5 EpiC cultures were still apparent even after 24 h of culture (Fig. 3A) . The migration abilities of E11.5, E13.5, and E15.5 EpiCs decreased as embryonic development progressed (Fig. 3B) . To eliminate the effect of gelatin solution on EpiC migration ability, 6-well plates without gelatin was used as the control. The results showed that the migration of these cells cultured in gelatin solution had no statistical differences, when compared with those cultured in no-gelatin solution in vitro (Fig. 3B) .
Proliferation ability of E11.5 EpiCs is weaker than E13.5, and E15.5 EpiCs
The precise relationship between embryonic day and proliferation capacity had not been thoroughly evaluated. All EpiCs were positive for Ki67 expression (Fig. 1F) , and DMEM/10%FBS might be sufficient to stimulate EpiC proliferation. The proliferation abilities of E11.5, E13.5, and E15.5 EpiCs were evaluated using cell cycle analysis (Fig. 4A) . Cell cycle analysis demonstrated that the proliferation ability of E11.5 EpiCs was significantly weaker than those of E13.5 and E15.5 EpiCs, and that the proliferation abilities of E13.5 and E15.5 EpiCs are not different ( Table 2) . To eliminate the effect of gelatin solution on the proliferation ability of EpiC, the 6-well plates without gelatin was used as the control. The results showed that the proliferation of the cells cultured in gelatin solution is not statistically different from that of the cells cultured in no-gelatin solution in vitro (Fig. 4B) .
PDGF-BB induces SMC differentiation of E11.5, E13.5 and E15.5 EpiCs E15.5 EpiCs were cultured for 2 days to induce differentiation. Mesenchymal cells were frequently observed at the periphery of the spread EpiCs treated with PDGF-BB (Fig. 5B) , but not in control BSA-treated cells (Fig. 5A) . ZO-1 expression was decreased or even disappeared in EpiCs treated with PDGF-BB for 2 days (Fig. 5K) . Over 4 days of culture, substantial mesenchymal cells were evident at the periphery of EpiCs treated with PDGF-BB (Fig. 5D) . The morphology of some EpiCs cultured for 7 days in PDGF-BBsupplemented culture medium showed irregular SMC-like shape (Fig. 5F ). Some EpiCs expressed SMC markers, including MYH11 and α-SMA, as detected by immunofluorescence (Fig. 5I,J) . After E11.5 and E13.5 EpiCs were treated with PDGF-BB for almost 1 week, these cells presented irregular morphology (Fig. 5G,H) and expressed SMC markers. To determine if the cultured EpiCs have also acquired the endothelial cell phenotype, EpiCs were immunofluorescently stained for endothelial cell marker CD31 (platelet/ endothelial cell adhesion molecule 1). The results showed that no CD31 was expressed in these cultured EpiCs (Fig. 5L) .
Primary culture of tracing EpiCs from double heterozygous mice
Tbx18-Cre knock-in heterozygous female mouse was mated with the male conditional Cre reporter mice Rosa26R EYFP (Fig. 6E) , and the Tbx18-Cre/Rosa26R lacZ double heterozygous EpiCs can be stained blue by X-gal staining solution (Fig. 6F) . Thus, Tbx18-Cre/Rosa26R EYFP double heterozygous EpiCs were induced using PDGF-BB for tracing the differentiation fate of Tbx18 + EpiCs in vitro. Some of those EpiCs co-expressed α-SMA and EYFP after treatment (Fig. 6B, yellow arrow) .
Early stage EpiCs are more prone to express SMC marker than later stage EpiCs with PDGF-BB treatment
To analyze the differences of differentiation potential in different embryonic day EpiCs, SMC differentiation of E11.5, E13.5, and E15.5 tracing Tbx18-Cre/Rosa26R EYFP EpiCs was induced by PDGF-BB treatment. The number of α-SMA + cells in all EYFP + cells in early stage EpiCs was higher than that in later stage EpiCs during the same culture time with PDGF-BB induction (Fig. 6A-C) . According to the literature [34] with appropriate adjustments, the SMC differentiation ratio of EpiCs with PDGF-BB induction was evaluated by the proportion of α-SMA + cells in the total EYFP + cells.
The results indicated that early stage EpiCs were more prone to express SMC marker than later stage EpiCs with PDGF-BB treatment (Fig. 6G) , indicating that the progenitor cell characteristics of early stage EpiCs is better than those of later stage EpiCs.
Discussion
WT-1 and TBX18 are expressed in proepicardial cells and continue to be expressed in the EpiCs [13, 18, 33] . Deletion of the TBX18 and WT1 genes in vivo will help studying their important functions in epicardial development [35, 36] . Primary EpiC culture provides an alternative method for studying the detailed mechanisms by which TBX18 and WT1 are involved in epicardial development [20] . Avian embryos [5] and mouse embryos are the main existing sources of embryonic EpiCs, while neonatal mice [37] and neonatal rats [38] are sources for neonatal EpiCs, and adult zebrafish [39] , adult mice [40] and human adults [41] are main sources for adult EpiCs. Because mouse embryos are easy to obtain and have high gene homology with humans, they are currently the main source of embryonic EpiCs [17, 18, 20, 21, 23] . Mouse embryonic ventricle cultures can be used to obtain highly pure EpiCs [20] . In this study, we observed that the purity of EpiCs correlated with the embryonic day. The purity of EpiCs from later stage embryonic ventricles was higher than that of EpiCs from early stage embryonic ventricles perhaps because later stage embryonic ventricles are larger and easily handled and because the outflow tract is more completely removed and can maintain the relative integrity of the ventricular tissue (Fig. 6D) , thus reducing contamination by other cells migrating off the excised heart. EpiCs continue to proliferate and spread for the EP to completely cover the surface of the cardiac muscle and further participate in normal heart development through migration and differentiation [1, 2] . Inhibition of PDGF signaling in vivo decreases EpiC proliferation, and impairs coronary blood vessel formation during heart regeneration in Figure 3 . Migration of different embryonic day EpiCs (A) Cell migration was analyzed by introducing a scratch into the cell mass and measuring scratch width at 0 and 24 h. E11.5 displayed complete scratch closure after 24 h, whereas the scratch was still apparent in E13.5 and E15.5. (B) Graph shows the fold decreases in E13.5 and E15.5 EpiC migration compared with E11.5 EpiCs, and there is no difference in the migration of E11.5, E13.5, or E15.5 EpiCs cultured in gelatin solution compared with those cultured in no-gelatin solution, *P < 0.05. The data represent the results of 3 independent experiments.
zebrafish [42] . Loss of neurofibromin 1 causes increased EPDC proliferation and results in larger numbers of cardiac fibroblasts and cSMCs [43] . Epicardial proliferation is the basis for migration and differentiation. We used cell cycle analysis to explore the changes in proliferation. Although the proliferation ability of E11.5 EpiCs was significantly weaker than those of E13.5 and E15.5 EpiCs, the proliferation abilities of E13.5 and E15.5 EpiCs did not differ. Perhaps EpiCs have maintained strong proliferation abilities because of their involvement in the development of the myocardium and coronary vessels during a critical period of embryonic development.
Epicardial motility is required for EpiC invasion of the myocardium. Deletion of PDGFR or TBX5 leads to delayed EPDC invasion of the compact myocardium, resulting in thinned compact myocardium and coronary vascular defects [17, 19, 44] . The migration abilities of E11.5, E13.5, and E15.5 EpiCs decreased as embryonic development progressed as determined by scratch assay. During midgestation (E10.5-E11.5), the migration ability of EpiCs is maximal, which is coincident with the formation of the EP. The migration capacity of EpiCs diminishes rapidly between E11.5 and E15.5. Perhaps because EP has been formed, a subset of EpiCs undergoes EMT to invade the underlying myocardium, with a continuous loss of migration ability in situ. This result is consistent with the reported findings in the literature [40] . The migration ability of EpiCs continues to decrease with development, while their proliferation ability only changes slightly, therefore, later stage embryonic ventricle explants require a prolonged culture time for the isolation of EpiCs.
One report indicated that EpiCs could contribute to the cardiomyocyte population only before E11.5 [12] . The expression of α-SMA (smooth muscle cells) and Tie2 (endothelial cells) significantly diminished in E12.5 EpiCs in response to thymosin β4 treatment and continued to decrease by E16.5 [45] . Trophic activity of the EP decreases and the ability to stimulate fetal cardiomyocyte proliferation is lost during development [37] . These findings may be related to the changes in the differentiation potential of EpiCs, which is the key to their participation in the development of cardiac tissue. Thus, revealing the changes in epicardial differentiation potential is of great significance. We found that early stage EpiCs were more prone to undergo mesenchymal transition than later stage EpiCs in normal serum medium within a week, suggesting that early stage EpiCs were more sensitive to PDGF-BB treatment and more prone to express SMC marker than later stage EpiCs, because the later stage epicardial differentiation potential decreases as embryonic development progresses. However, how much potential is lost during differentiation from E11.5 to E15.5 remains unclear. The proportion of different phase was represented by the mean ± standard deviation, n = 6 in each group. * P < 0.05, E11.5 compared with E13.5 and E15.5 in the same phase of cell cycle.
In vivo studies have indicated that the PDGF-B-PDGFR-β signaling pathway is involved in the differentiation of cSMCs. PDGFR-β is expressed in E13.5, E15.5 and E17.5 mouse EP [17, 19] . Studies have shown that PDGF-B can be combined with PDGFR-β in vitro [46] , and in vitro studies have indicated that PDGF-BB can strongly induce proepicardial cell differentiation [30] . We used PDGF-BB to induce E11.5, E13.5, and E15.5 EpiCs. This treatment altered cell morphology and SMC marker expression after 1 week, thus illustrating the properties and differentiation abilities of progenitor cells. We observed that some TBX18 + EpiCs did not express SMC marker after being induced (Fig. 6B , white arrow), suggesting that these cells might be fibroblasts or undifferentiated progenitor cells. In vivo studies have confirmed that a subset of TBX18 + EpiCs could differentiate into fibroblasts [12] .
Serum medium can provide sufficient nutrients for cell growth, and almost all the existing methods for isolating EpiCs from excised heart include culture in medium containing high serum level [17, 20, 21, 23] . E11.5 EpiCs have been shown to migrate off an excised heart in serum-free medium [18] . Directly studying the effects of special paracrine factors on EpiCs under serum-free conditions is useful because it avoids the intervention of other growth factors in the serum. We selected E11.5, E13.5 and E15.5 embryonic ventricle explants to culture and to determine the abilities of different embryonic day EpiCs to migrate off under serum-free condition. A certain amount of EpiCs were able to migrate out from the E11.5 embryonic ventricle explants in serum-free medium. Moreover, EpiCs scarcely migrated out from E13.5 and E15.5 embryonic ventricle explants under serum-free condition even with long-term culture, perhaps because EpiCs also retain strong proliferation, migration and adaptation abilities like early stem cells when the EP is fully matured. A similar method was used to culture highly pure proepicardial cells under serum-free condition [47] .
Although different biological characteristics of different embryonic day EpiCs were demonstrated in this study, some experimental limitations still exist. There were different biological characteristics in different embryonic day EpiCs in vitro; however, these differences need to be confirmed in vivo. Therefore, the in vitro results here may only be a reference for in vitro explants to culture primary EpiCs. According to different experimental purposes, choosing different embryonic day ventricle explants to culture EpiCs is appropriate.
Recently, neonatal mouse hearts were shown to regenerate after myocardial injury in a similar fashion to adult zebrafish [48, 49] . EpiCs may be involved in myocardial regeneration [25, 48, 50] . The EpiCs of neonatal mouse in vitro can provide an alternative approach for studying the participation of EpiCs in neonatal mouse cardiac regeneration potential and for determining a possible specific mechanism. According to the literature [39] , we isolated the postnatal day 1 (P1) ventricular apex and positioned it with the apex facing down on gelatin-coated plates in DMEM/10% FBS. EP-like cells can migrate out of the explant but are accompanied by fibroblast-like cells (data not shown). The migration and proliferation abilities of EpiCs are likely sharply reduced and nutrient factor secretion by EpiCs decreases after birth. Thus, EpiCs can not inhibit fibroblast growth.
In summary, our results indicate that EpiCs isolated from E11.5, E13.5, and E15.5 ventricular explants differ in some of their functional properties. SMC differentiation potential and migration abilities decrease with embryonic age of the explant. However, there is no significant difference in the proliferation ability between EpiCs isolated from E13.5 and EpiCs isolated from E15.5 ventricular tissue. The different biological characteristics of different embryonic day EpiCs may provide a reference for future in vitro experiments that require primary EpiCs.
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